InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,304.72
(
0.70%
)
US TECH 100
18,318.00
(
0.00%
)
Dow Jones
39,069.59
(
0.01%
)
Brent Oil
83.02
(
0.21%
)
Bitcoin
67,841.85
(
-2.24%
)
Post# of 158400
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

ADVFN_franknstein

Send PM Follow Ignore
Followers 27
Posts 3592
Boards Moderated 0
Alias Born 08/16/2013

ADVFN_franknstein

Re: sizzleweed post# 153962

Saturday, 12/19/2015 6:46:58 AM

Saturday, December 19, 2015 6:46:58 AM

Post# of 158400

Each news release lists RGBP as a controlled subsidiary of Bio Matrix


This is correct for SEC filings like the 8-k, 10-Q ...
But nor for press releases !
Starting with the press release June 12, 2015 BMSN is no longer mentioned in Regens PR's.

About Regen BioPharma, Inc.
Regen BioPharma Inc. is a publicly traded biotechnology company (OTCBB: RGBP) and (OTC PINK: RGBP). The Company seeks to identify undervalued regenerative medicine applications in the immunotherapy and stem cell space. The Company is focused on rapidly advancing these technologies through pre-clinical and Phase I/ II clinical trials. Currently the Company is centering on gene silencing therapy for treating cancer, telomeres and small molecule therapies, along with developing stem cell treatments for aplastic anemia.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up